The FDA has approved Inrebic for the treatment of adult patients with certain types of myelofibrosis, a rare bone marrow disorder. 

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

Roche has priced its cancer treatment Rozlytrek at $17,050 per month, about half the cost of a similar drug sold by Eli Lilly and Bayer, according to STAT.

An unnamed manager at Novartis sold $946,000 worth of company shares less than three weeks before a scandal involving manipulated data became public, according to Bloomberg. 

Between 2011 and 2017, Medicare could have saved $17.7 billion if generic versions of older medicines were prescribed instead of updated brand-name drugs launched by drugmakers to replace their older off-patent pills, according to a new study published in the…

The FDA has approved Rozlytrek, Roche's personalized cancer treatment that targets tumors with a specific genetic mutation.

Pfizer is recalling two lots of Relpax, tablets to treat migraines, due to bacterial contamination concerns.

PharmacyChecker.com, an online pharmacy verification service provider, accused several pharmaceutical associations of reaching agreements with online gatekeepers like Google and Bing to suppress its online presence, according to STAT. 

A former employee at Vasconi's Pharmacy in St. Helena, Calif., was arrested last week on felony charges of embezzlement, according to the Napa Valley Register.

Pharmacy benefit managers negotiated $18 billion worth of rebates from drugmakers in Medicare Part D and retained less than 1 percent of those rebates in 2016, according to a recent Government Accountability Office report.